SWAPNIL JATINBHAI SHAH is registered with Ministry of Corporate Affairs (MCA) having DIN/PAN 05259821. SWAPNIL JATINBHAI SHAH is director/partner/authorized signatory in 9 company or LLP.
DIN status of SWAPNIL JATINBHAI SHAH is Active. SWAPNIL JATINBHAI SHAH is not the director of any ACTIVE non-compliant company.DIN of SWAPNIL JATINBHAI SHAH was approved on 20-04-2012.
Following is the current and past directorship/partnerships of SWAPNIL JATINBHAI SHAH, SENORES PHARMACEUTICALS LIMITED, RATNATRIS PHARMACEUTICALS PRIVATE LIMITED, SUMER ENTERPRISES LLP, RENOSEN PHARMACEUTICALS PRIVATE LIMITED, RATNAGENE LIFESCIENCE PRIVATE LIMITED, AELIUS PROJECTS LLP, REMUS PHARMACEUTICALS LIMITED, RELIUS LIFESCIENCES PRIVATE LIMITED, ESPEE THERAPEUTICS LLP
| DIN | 05259821 |
| Director Name | SWAPNIL JATINBHAI SHAH |
| DIN Status | Active |
| Date of Approval | 20th April, 2012 |
| Director of Active non-compliant company | No |
| DIR-3 KYC Status | Done |
| DSC Status | NA |
| DSC Expiry Date | NA |
| Company | CIN/LLPIN | Designation | Appointment |
|---|---|---|---|
| SENORES PHARMACEUTICALS LIMITED | U24290GJ2017PLC100263 | Director | 26th December, 2017 |
| RATNATRIS PHARMACEUTICALS PRIVATE LIMITED | U24230GJ2005PTC047394 | Director | 15th January, 2021 |
| SUMER ENTERPRISES LLP | AAN-1429 | Designated Partner | 13th August, 2018 |
| RENOSEN PHARMACEUTICALS PRIVATE LIMITED | U51909GJ2019PTC108258 | Director | 22nd May, 2019 |
| RATNAGENE LIFESCIENCE PRIVATE LIMITED | U24231GJ2021PTC125613 | Director | 15th September, 2021 |
| AELIUS PROJECTS LLP | AAP-1775 | Designated Partner | 3rd May, 2019 |
| REMUS PHARMACEUTICALS LIMITED | L24232GJ2015PLC084536 | Director | 21st September, 2015 |
| RELIUS LIFESCIENCES PRIVATE LIMITED | U24299GJ2016PTC094454 | Director | 21st November, 2016 |
| ESPEE THERAPEUTICS LLP | AAH-8938 | Designated Partner | 25th November, 2016 |
Disclaimer : This information is best of our knowledge. Some information may or may not be fully accurate